4.4 Review

A review of metabolism-associated biomarkers in lung cancer diagnosis and treatment

Journal

METABOLOMICS
Volume 14, Issue 6, Pages -

Publisher

SPRINGER
DOI: 10.1007/s11306-018-1376-2

Keywords

Cancer metabolomics; Lung cancer; Metabolism biomarkers; Cancer diagnosis; Cancer treatment

Funding

  1. National Institutes of Health/National Cancer Institute [R15CA203605]
  2. NATIONAL CANCER INSTITUTE [R15CA203605] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Lung cancer continues to be the leading cause of cancer-related mortality worldwide. Early detection has proven essential to extend survival. Genomic and proteomic advances have provided impetus to the effort dedicated to detect and diagnose the disease at an earlier stage. Recently, the study of metabolites associated with tumor formation and progression has inaugurated the era of cancer metabolomics to aid in this effort. This review summarizes recent work regarding novel metabolites with the potential to serve as biomarkers for early lung tumor detection, evaluation of disease progression, and prediction of patient outcomes. We compare the metabolite profiling of cancer patients with that of healthy individuals, and the metabolites identified in tissue and biofluid samples and their usefulness as lung cancer biomarkers. We discuss metabolite alterations in tumor versus paired non-tumor lung tissues, as well as metabolite alterations in different stages of lung cancers and their usefulness as indicators of disease progression and overall survival. We evaluate metabolite dysregulation in different types of lung cancers, and those associated with lung cancer versus other lung diseases. We also examine metabolite differences between lung cancer patients and smokers/risk-factor individuals. Although an extensive list of metabolites has been evaluated to distinguish between these cases, refinement of methods is further required for adequate patient diagnosis and treatment. We conclude that with technological advancement, metabolomics may be able to replace more invasive and costly diagnostic procedures while also providing the means to more effectively tailor treatment to patient-specific tumors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

Multi-objective optimization of tumor response to drug release from vasculature-bound nanoparticles

Ibrahim M. Chamseddine, Hermann B. Frieboes, Michael Kokkolaras

SCIENTIFIC REPORTS (2020)

Correction Oncology

Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment (Nov, 10.1007/s00262-020-02785-4, 2020)

Louis T. Curtis, Susanne Sebens, Hermann B. Frieboes

Summary: The original version of the article contains a mistake that needs to be corrected.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Article Multidisciplinary Sciences

Impact of tumor-parenchyma biomechanics on liver metastatic progression: a multi-model approach

Yafei Wang, Erik Brodin, Kenichiro Nishii, Hermann B. Frieboes, Shannon M. Mumenthaler, Jessica L. Sparks, Paul Macklin

Summary: This study examines the biomechanical interactions between tumor and liver parenchyma during metastatic growth, using a multi-model approach. It investigates the role of these interactions in promoting liver metastasis and aims to identify conditions to clinically arrest and reverse the course of late-stage cancer.

SCIENTIFIC REPORTS (2021)

Article Endocrinology & Metabolism

Discrepancies in metabolomic biomarker identification from patient-derived lung cancer revealed by combined variation in data pre-treatment and imputation methods

Hunter A. Miller, Ramy Emam, Chip M. Lynch, Samuel Bockhorst, Hermann B. Frieboes

Summary: This study systematically examines the combined role of data pre-treatment and imputation methods on the performance of multivariate data analysis methods and their identification of potential biomarkers. The choice of pre-treatment and imputation methods is critical in defining candidate biomarkers, with deficient or inappropriate selection leading to inconsistent results.

METABOLOMICS (2021)

Article Biology

Simulation of 3D centimeter-scale continuum tumor growth at sub-millimeter resolution via distributed computing

Dylan A. Goodin, Hermann B. Frieboes

Summary: Simulation of cm-scale tumor growth has been traditionally constrained by computational cost, with models limited to mm-scale or smaller tumors. This study presents a distributed computing implementation of a mixture model to simulate 3D cm-scale vascularized tissue at sub-mm resolution, using a two-stage parallelization framework with CUDA and MPI. Results show that this approach enables continuum modeling of cm-scale tumors at reasonable computational cost.

COMPUTERS IN BIOLOGY AND MEDICINE (2021)

Article Oncology

Evaluation of disease staging and chemotherapeutic response in non-small cell lung cancer from patient tumor-derived metabolomic data

Hunter A. Miller, Xinmin Yin, Susan A. Smith, Xiaoling Hu, Xiang Zhang, Jun Yan, Donald M. Miller, Victor H. van Berkel, Hermann B. Frieboes

Summary: This study explores predictive models for staging and chemotherapy response in non-small cell lung cancer based on metabolomic analysis of patient-derived core biopsies. Machine learning techniques were applied to differentiate between different disease statuses and treatment responses with high accuracy. The results demonstrate the potential for comprehensive evaluation of patient-specific metabolic profiles to guide clinical decision-making.

LUNG CANCER (2021)

Article Engineering, Biomedical

Modeling of Tumor Growth with Input from Patient-Specific Metabolomic Data

Hunter A. Miller, John Lowengrub, Hermann B. Frieboes

Summary: This study combines tumor metabolomic data with mathematical modeling for personalized simulation of tumor progression, providing a first step towards evaluating tumor growth based on metabolomic data.

ANNALS OF BIOMEDICAL ENGINEERING (2022)

Article Engineering, Biomedical

Evaluation of Lung Cancer Patient Response to First-Line Chemotherapy by Integration of Tumor Core Biopsy Metabolomics with Multiscale Modeling

Hunter A. Miller, Donald M. Miller, Victor H. van Berkel, Hermann B. Frieboes

Summary: This study used a multiscale modeling approach to evaluate the response of non-small cell lung cancer patients to first-line chemotherapy based on metabolomic analysis of tumor tissue. The results showed significant differences in patient classifications, providing a first step towards personalized lung cancer treatment prognosis.

ANNALS OF BIOMEDICAL ENGINEERING (2023)

Article Immunology

Multiple breast cancer liver metastases response to macrophage-delivered nanotherapy evaluated via a 3D continuum model

Dylan A. Goodin, Eric Chau, Anjana Tiwari, Biana Godin, Hermann B. Frieboes

Summary: Breast cancer liver metastases (BCLM) are difficult to treat with chemotherapy due to poor drug transportation. By targeting tumour-associated macrophages (TAM), the use of nanoalbumin-bound paclitaxel encapsulated in porous silicon multistage nanovectors (MSV) can improve therapeutic efficacy. Computational modeling allows for the evaluation and optimization of MSV-nab-PTX therapy for multiple BCLM.

IMMUNOLOGY (2023)

Article Pharmacology & Pharmacy

Formulation and characterization of pressure-assisted microsyringe 3D-printed scaffolds for controlled intravaginal antibiotic release

Anthony J. Kyser, Mohamed Y. Mahmoud, Sydney E. Herold, Warren G. Lewis, Amanda L. Lewis, Jill M. Steinbach-Rankins, Hermann B. Frieboes

Summary: This study formulates and characterizes novel metronidazole-containing 3D-printed silicone scaffolds for sustained antibiotic delivery to the female reproductive tract. The scaffolds showed high structural integrity and sustained release in simulated vaginal fluid. This study suggests that pressure-assisted microsyringe 3D-printed silicone scaffolds may be a versatile vehicle for sustained metronidazole delivery.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)

Article Materials Science, Biomaterials

Development and Characterization of Lactobacillus rhamnosus -Containing Bioprints for Application to Catheter-Associated Urinary Tract Infections

Anthony J. Kyser, Mohamed Y. Mahmoud, Nicholas T. Johnson, Bassam Fotouh, Jill M. Steinbach-Rankins, Nicole M. Gilbert, Hermann B. Frieboes

Summary: Catheter-associated urinary tract infections (CAUTI) are a significant healthcare burden. This study demonstrates the potential use of 3D bioprinting to create silicone catheters containing probiotic lactobacilli, which can release active compounds and potentially prevent or treat CAUTI.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2023)

Article Endocrinology & Metabolism

Lung cancer survival prediction and biomarker identification with an ensemble machine learning analysis of tumor core biopsy metabolomic data

Hunter A. Miller, Victor H. van Berkel, Hermann B. Frieboes

Summary: This study demonstrates the feasibility of using an ensemble machine learning approach to accurately predict patient survival based on metabolomic biomarkers from tumor core biopsies. The analysis of tumor tissue allows for a more accurate reflection of cancer metabolism and its impact on survival. The researchers identified a set of reliable biomarkers with potential clinical utility, which outperformed traditional predictors in predicting overall survival and progression-free survival.

METABOLOMICS (2022)

Article Endocrinology & Metabolism

Lung cancer metabolomic data from tumor core biopsies enables risk-score calculation for progression-free and overall survival

Hunter A. Miller, Shesh N. Rai, Xinmin Yin, Xiang Zhang, Jason A. Chesney, Victor H. van Berkel, Hermann B. Frieboes

Summary: Metabolomic analysis of lung tumor core biopsies, combined with covariates, successfully stratified patients into low- and high-risk groups for predicting overall survival and progression-free survival.

METABOLOMICS (2022)

Article Oncology

Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment

Louis T. Curtis, Susanne Sebens, Hermann B. Frieboes

Summary: The study develops a modeling system to evaluate the effects of macrophage and T-lymphocyte interactions on tumor growth, highlighting the dynamic interactions in the tumor microenvironment. The results show that increasing the M1:M2 ratio may not achieve tumor regression due to saturation of the overall cytotoxic effect from macrophages and T-lymphocytes. Further expansion of the modeling platform could enable systematic evaluation of immunotherapeutic strategies tailored to specific tumor conditions.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Article Computer Science, Information Systems

Personalized Computer-Aided Diagnosis for Mild Cognitive Impairment in Alzheimer's Disease Based on sMRI and 11C PiB-PET Analysis

Fatma El-Zahraa A. El-Gamal, Mohammed M. Elmogy, Ashraf Khalil, Mohammed Ghazal, Jawad Yousaf, Xiaolu Qiu, Hassan H. Soliman, Ahmed Atwan, Hermann B. Frieboes, Gregory Neal Barnes, Ayman S. El-Baz

IEEE ACCESS (2020)

No Data Available